Event Preview

AusMedtech 2024: Australia’s medtech industry takes center stage

The seventeenth annual AusMedtech 2024 will gather key stakeholders of the Australian and international medtech sector.

22-23 May 2024 
Adelaide, South Australia


All image credit: AusBiotech

Australia’s booming medical technology industry will hit the spotlight once again at the AusMedtech 2024 conference in Adelaide, Australia from 20-24 May 2024.  

Known in the industry as Australia’s biggest week in medtech, the conference will be officially opened by the Hon Susan Close MP, Deputy Premier for South Australia, Minister for Industry, Innovation and Science, at the Adelaide Convention Centre. 

Caption. Credit: 

While therapeutics has traditionally dominated Australia’s biotech sector, the medical technology sector is rapidly growing and Australia is keen to flex its muscles as a world-leader in medtech, supported by strong innovation in areas such as genomic medicine, digital health, and precision medicine. 

The upcoming two-day conference will feature more than 400 local and international speakers, with keynotes from industry leaders and panel sessions highlighting the successful expansion and growth of Australian medtech companies in 2023-24. Trending topics including artificial intelligence and environmental, social, and governance strategies will be explored in depth.

With sweeping reforms occurring across the globe in medical device regulation, other sessions will focus on how Australia’s Therapeutic Goods Administration (TGA) agency is supporting the industry through changes and what these policies really mean for Australian patients.

Caption. Credit: 

AusBiotech Board member and Cochlear Vice President of Medical Affairs, Market Access & Government Affair, Asia-Pacific, Dell Kingsford Smith is set to host a plenary session with big medtech on partnering in the Australian environment.

Participants will be invited to tour South Australia’s life sciences ecosystem including Adelaide BioMed City, Lot Fourteen, Tonsley Innovation District, Mawson Lakes, and the Australian National Fabrication Facility – South Australia.

Caption. Credit: 

AusMedtech’s Early-Stage Innovation Forum will feature rapid fire rounds of quick-pitch presentations on early-stage technologies and projects from local research institutes, universities, hospitals, and pre-series A companies in the areas of medical devices and diagnostics, digital health and enabling technologies.

On the first day of the event, delegates will be invited to join a conference dinner for an evening of networking opportunities and a fireside chat with Red Dust founders, Pintupi man Jonathan Hermawan and CEO Scott Stirling.

With Australia’s indigenous communities overrepresented in low socioeconomic figures, Australia’s First Nations people face a greater risk of poor health, higher rates of illness, disability, and death, and live shorter lives than people from higher socioeconomic groups. Providing a ‘community-as-family’ model of health and well-being programmes, Red Dust works alongside community leaders and elders to create a stronger future for indigenous youth and their families.

Further conference details can be found on the AusMedtech 2024 website. Registrations now open.

Contact information


Tel: +61 491 909 710
Email: events@ausbiotech.org